198 related articles for article (PubMed ID: 36316102)
1. Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.
Brucato A; Wheeler A; Luis SA; Abbate A; Cremer PC; Zou L; Insalaco A; Lewinter M; Lewis BS; Lin D; Nicholls S; Pancrazi M; Klein AL; Imazio M; Paolini JF
Heart; 2023 Jan; 109(4):297-304. PubMed ID: 36316102
[TBL] [Abstract][Full Text] [Related]
2. RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis.
Klein AL; Imazio M; Brucato A; Cremer P; LeWinter M; Abbate A; Lin D; Martini A; Beutler A; Chang S; Fang F; Gervais A; Perrin R; Paolini JF
Am Heart J; 2020 Oct; 228():81-90. PubMed ID: 32866928
[TBL] [Abstract][Full Text] [Related]
3. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
Klein AL; Imazio M; Cremer P; Brucato A; Abbate A; Fang F; Insalaco A; LeWinter M; Lewis BS; Lin D; Luis SA; Nicholls SJ; Pano A; Wheeler A; Paolini JF;
N Engl J Med; 2021 Jan; 384(1):31-41. PubMed ID: 33200890
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY.
Brucato A; Lim-Watson MZ; Klein A; Imazio M; Cella D; Cremer P; LeWinter MM; Luis SA; Lin D; Lotan D; Pancrazi M; Trotta L; Klooster B; Litcher-Kelly L; Zou L; Magestro M; Wheeler A; Paolini JF;
J Am Heart Assoc; 2022 Oct; 11(20):e023252. PubMed ID: 36250662
[TBL] [Abstract][Full Text] [Related]
5. Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept.
Imazio M; Klein AL; Brucato A; Abbate A; Arad M; Cremer PC; Insalaco A; LeWinter MM; Lewis BS; Lin D; Luis SA; Nicholls SJ; Sutej P; Wasserstrum Y; Clair J; Agarwal I; Wang S; Paolini JF;
J Am Heart Assoc; 2024 Mar; 13(6):e032516. PubMed ID: 38471825
[TBL] [Abstract][Full Text] [Related]
6. Rilonacept for the treatment of recurrent pericarditis.
Fava AM; Reyaldeen R; Lo Presti S; Goyal A; Akintoye E; Hughes D; Klein AL
Expert Opin Biol Ther; 2022 Jan; 22(1):7-16. PubMed ID: 34757872
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept.
Lin D; Klein A; Cella D; Beutler A; Fang F; Magestro M; Cremer P; LeWinter MM; Luis SA; Abbate A; Ertel A; Litcher-Kelly L; Klooster B; Paolini JF
BMC Cardiovasc Disord; 2021 Apr; 21(1):201. PubMed ID: 33882846
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial.
Klein AL; Lin D; Cremer PC; Nasir S; Luis SA; Abbate A; Ertel A; LeWinter M; Beutler A; Fang F; Paolini JF
Heart; 2020 Nov; 107(6):488-96. PubMed ID: 33229362
[TBL] [Abstract][Full Text] [Related]
9. Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.
Schwier NC
Ann Pharmacother; 2022 May; 56(5):572-581. PubMed ID: 34459270
[TBL] [Abstract][Full Text] [Related]
10. Does colchicine decrease the rate of recurrence of acute idiopathic pericarditis treated with glucocorticoids?
Mager A; Talmor Y; Chezar Azzerad C; Iakobishvili Z; Porter A; Kornowski R; Hasdai D
J Cardiol; 2018 Apr; 71(4):409-413. PubMed ID: 29198919
[TBL] [Abstract][Full Text] [Related]
11. Recurrent pericarditis: an update on diagnosis and management.
Vecchiè A; Dell M; Mbualungu J; Ho AC; VAN Tassell B; Abbate A
Panminerva Med; 2021 Sep; 63(3):261-269. PubMed ID: 33618510
[TBL] [Abstract][Full Text] [Related]
12. What is rilonacept's role in treating recurrent pericarditis?
Schwier NC
JAAPA; 2022 Nov; 35(11):18-19. PubMed ID: 36282574
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment of acute and recurrent pericarditis: a systematic review and meta-analysis of controlled clinical trials.
Avondo S; Andreis A; Casula M; Biondi-Zoccai G; Imazio M
Panminerva Med; 2021 Sep; 63(3):314-323. PubMed ID: 34738773
[TBL] [Abstract][Full Text] [Related]
14. Recurrent pericarditis in children and adolescents: a multicentre cohort study.
Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A
J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459
[TBL] [Abstract][Full Text] [Related]
15. A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option.
Gupta M; Kaul S; Velazquez GR; Bandyopadhyay D; Fonarow GC; Klein A; Ghosh RK
Am J Cardiovasc Drugs; 2022 Jan; 22(1):27-33. PubMed ID: 34008144
[TBL] [Abstract][Full Text] [Related]
16. Advances in pharmacotherapy for acute and recurrent pericarditis.
Vecchié A; Del Buono MG; Mauro AG; Cremer PC; Imazio M; Klein AL; Abbate A; Dentali F; Bonaventura A
Expert Opin Pharmacother; 2022 Apr; 23(6):681-691. PubMed ID: 35311434
[TBL] [Abstract][Full Text] [Related]
17. The Role of Rilonacept in Recurrent Pericarditis.
Presti SL; Elajami TK; Reyaldeen R; Anthony C; Klein AL
Heart Int; 2021; 15(1):20-25. PubMed ID: 36277322
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Pericarditis: Modern Approach in 2016.
Imazio M; Adler Y; Charron P
Curr Cardiol Rep; 2016 Jun; 18(6):50. PubMed ID: 27108360
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial.
Imazio M; Belli R; Brucato A; Cemin R; Ferrua S; Beqaraj F; Demarie D; Ferro S; Forno D; Maestroni S; Cumetti D; Varbella F; Trinchero R; Spodick DH; Adler Y
Lancet; 2014 Jun; 383(9936):2232-7. PubMed ID: 24694983
[TBL] [Abstract][Full Text] [Related]
20. Colchicine for pericarditis.
Alabed S; Cabello JB; Irving GJ; Qintar M; Burls A
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010652. PubMed ID: 25164988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]